View Report Details Global Blood Plasma Market Report ----------------------------------------2016
View Report Details Executive Summary
The raw material for blood plasma industry is the liquid that is a component of blood called blood plasma. Blood plasma makes up approximately 55% of the total blood volume. Blood plasma is pale yellow in color and consists of water, proteins and salt. Those proteins are used to produce medicinal products for treatment of a variety of life-threatening diseases, illnesses and conditions. These plasma-derived medications are the standard course of treatment for thousands of people, in more than 100 countries across the globe, who need the treatment to improve their health and lead productive lives.
The chief components of the global blood plasma market are immunoglobulin, albumin, factor VIII and Alpha-1 proteinase inhibitor (A1PI) or alpha-1 antitrypsin (AAT). These components are proteins and antibodies that are extracted from the fractionated blood plasma and used for the treatment of various indications.
The key factors which are anticipated to drive this market include rising healthcare expenditure, growing demand for polyvalent immunoglobulin and increasing market for albumin in the Asia-pacific. Some of the noteworthy progresses of this industry include the new potential for raising AATD diagnosis and introduction of extended half-life products for hemophilia. However, the growth of respective industry is challenged by the high cost of production that discourages new entrants, shrinking market for plasma-derived factor VIII, high industry regulation in the emerging market and increasing threat of substitutes.
The report provides a wide-ranging study of global blood plasma market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are examined in depth. The global blood plasma market is highly competitive consisting of several large conglomerates including Baxter international, CSL, Grifols, Octapharma etc. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
The global blood plasma market consists of several plasma-derived products, primarily proteins that help treating various rare and congenital diseases as well as deficiencies in the human body. Global Blood Plasma Market Revenue (2013-2018F)
Global Immunoglobulin Market Revenue (2013-2018F)
•
The global blood plasma market revenue for the year 2015 is noted to be US$xxx billion. The market revenue is set to grow at a CAGR of xx.0x% over the period spanning 2015-2018, attaining a value of nearly US$xxx billion in the year 2018.
•
The global immunoglobulin market has grown by nearly xx % over the previous year due to growth in volume and a stable price environment. It is forecasted that the market revenue will grow at a CAGR of xx.x% over the period spanning 2015-2018, reaching nearly US$xxx billion by the end of 2018.
•
The global albumin market revenue reached US$xxx billion in the year 2015, marking a growth of ….% from the previous year. It is forecasted that the revenue will continue to grow further at a CAGR …% over the period 2015-2018F Global Albumin Market Revenue (2013-2018F)
The US has one of the largest markets for immunoglobulin in the world, accounting to nearly half of the global immunoglobulin revenue The US Plasma Fractionation Capacity – Actuals (2012-2015E)
The US Immunoglobulin Market Revenue (2013-2018F)
•
The US blood plasma fractionation capacity has witnessed a gradual growth over time. In the year 2014, the US plasma fractionation capacity was recorded to be xxx million litres and it is estimated to have risen to xxx5 million litres in the year 2015.
•
The US immunoglobulin revenue for 2014 was recorded to be US$xx billion and is estimated to be US$xx billion for the year 2015, witnessing an expected growth of ….%. Besides, it is forecasted that this revenue shall continue to grow further at a CAGR of ….% during the period 2015-2018.
•
The US immunoglobulin sales volume in the year 2014 was recorded to be xx million grams and it has increased in the next year, adding up to xx million grams.
The US Immunoglobulin Market by Volume (2013-2020F)
The human albumin market accounts for more than half of the plasma product market in China. China Blood Plasma Market Revenue (2014-2020F) • China is one of the largest markets globally for plasma products. In 2014, the total market size of plasma products was valued at US$xx billion, which is estimated to have risen to US$xx billion in the year 2015. • The market revenue of human albumin reached US$xxx billion in 2014 and is estimated to have increased to US$xxx billion in the year 2015. The revenue is anticipated to increase to US$xx billion by the end of 2020. • The revenue from IG market in China was recorded to be US$xxx million in 2014, which is estimated to have risen to US$xxx million in 2015. The revenue is forecasted to grow at a CAGR of xx% over the period 2015-2020
China Human Albumin Market Revenue (2013-2020F)
China Immunoglobulin Market Revenue (2014-2020F)
Contact Us: View Report Details These are abridged and sanitized sample pages from the comprehensive report on the “ Global Blood Plasma Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com